Kallikrein-related peptidase 8 (KLK8) is one such protein that has been identified to be highly expressed in cervical, ovarian and endometrial cancers, indicating that it could be a viable target for therapy [254, 255]. This evidence concerns the gene KLK8 and endometrial cancer.